Medifirst Solutions Completes Distribution Agreeme
Post# of 1782
(Total Views: 135)
Posted On: 03/21/2019 9:34:34 AM
Medifirst Solutions Completes Distribution Agreement
Freehold, NJ, March 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services and Distributor of Dr. Gupta Pharma CBD, is pleased to provide a distribution update.
Regarding international distribution, Medifirst recently announced it is in the final stages of negotiation with a distribution company for distribution rights for its Infrared Laser for Latin America. Medifirst is pleased to announce that it has completed a distribution agreement with Dimex, a Guatemala based distribution company that covers Latin America. Countries that are being evaluated for sales and distribution for the Time Machine Laser include: Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Dominican Republic and Panama. Recent market research forecast strong growth in Latin America’s healthcare market, particularly when it comes to medical equipment and device sales.
Commented Medifirst President Bruce J. Schoengood, “We have completed our analysis of the registration process for each country and have identified Guatemala and El Salvador as the first two countries that we will begin prepping for registration for our US FDA cleared laser, which is an all-in-one unit, very effective and easy-to-use. Its benefits and affordability allows us to expand into new international markets such as Latin America. We are excited to be working with Dimex and by the extensive experience they bring.”
Sonia and Craig Van Sickle, owners of Dimex, stated, “We see a great opportunity for the Time Machine Laser in these growing new markets and are honored to have been selected to manage the distribution of a product that offers a revolutionary pain management solution therapy that is affordable and accessible. We believe there is a great need for all-natural and drug-free pain solutions in Latin America and we are thrilled to be introducing the Laser to bring new solutions for people who suffer from pain.”
Dr. Ronald L. Rubin, Medical Director for Medifirst, commented, “After five exciting years of clinical trials and patient care, we have seen the Time Machine Laser decrease and eliminate pain in the great majority of injuries whether at home, work, car or on the playing field. The efficacy and availability of our Laser is most timely with the worldwide opioid addiction crisis with far too many resultant deaths. We are committed to our mission to treat as many people as possible who are suffering with acute and chronic pain.”
Sonia Van Sickle has worked in business development for more than 25 years in the Latin American and US markets. For more than 15 years, she was in Marketing and Sales for Novartis Pharmaceutical in Latin America. She managed the distribution channels, legal, regulatory, logistics, marketing and sales of Novartis Ophthalmology, and OTC business units. She is a native of Guatemala, who currently lives in U.S., where she has continued to work in business development in the franchise world. She is also the current owner and Marketing Manager for Dimex S.A. in Guatemala, a company created for the import/export and distribution of products. Craig Van Sickle is the co-owner and General Manager of Dimex S. A. in Guatemala since 1995. He is introducing a new spa concept for South Florida and Puerto Rico for a successful Med Spa franchise which is one of the most successful business strategies in the market available today.
The company anticipates further related announcements and updates in the upcoming weeks and months.
About the Time Machine Laser
The Time Machine Laser is the only all-in-one, affordable, FDA cleared, Infrared, 2000mW power, small, hand-held portable laser marketed for pain relief in the U.S. The Time Machine Laser, which has been extensively tested and approved by Intertek for safety and electrical standards, has the power and frequency often found in large and expensive stationary units and at a fraction of the cost. Medifirst Solutions, Inc., in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Laser is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated tissue temperature from infrared spectral emissions. Visit www.medifirstsolutions.com for more information. Follow on Twitter @Medi_First and for Facebook visit Medifirst Solutions.
Forward-Looking Statements:
The statements in this press release that relate to the company’s expectations about the future impact on the company's results from new products in development are forward-looking statements, and may involve risks and uncertainties, some of which are beyond our control. Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission. Since the information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. We make no commitment to disclose any subsequent revisions to forward-looking statements. This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity.
Contact: Investor Relations
Phone: (732) 786-8044
Email: admin@medifirstsolutions.com
Website: www.medifirstsolutions.com
Source: Medifirst Solutions
Freehold, NJ, March 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device and a provider of Specialty Pharmacy Drug Consulting Services and Distributor of Dr. Gupta Pharma CBD, is pleased to provide a distribution update.
Regarding international distribution, Medifirst recently announced it is in the final stages of negotiation with a distribution company for distribution rights for its Infrared Laser for Latin America. Medifirst is pleased to announce that it has completed a distribution agreement with Dimex, a Guatemala based distribution company that covers Latin America. Countries that are being evaluated for sales and distribution for the Time Machine Laser include: Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Dominican Republic and Panama. Recent market research forecast strong growth in Latin America’s healthcare market, particularly when it comes to medical equipment and device sales.
Commented Medifirst President Bruce J. Schoengood, “We have completed our analysis of the registration process for each country and have identified Guatemala and El Salvador as the first two countries that we will begin prepping for registration for our US FDA cleared laser, which is an all-in-one unit, very effective and easy-to-use. Its benefits and affordability allows us to expand into new international markets such as Latin America. We are excited to be working with Dimex and by the extensive experience they bring.”
Sonia and Craig Van Sickle, owners of Dimex, stated, “We see a great opportunity for the Time Machine Laser in these growing new markets and are honored to have been selected to manage the distribution of a product that offers a revolutionary pain management solution therapy that is affordable and accessible. We believe there is a great need for all-natural and drug-free pain solutions in Latin America and we are thrilled to be introducing the Laser to bring new solutions for people who suffer from pain.”
Dr. Ronald L. Rubin, Medical Director for Medifirst, commented, “After five exciting years of clinical trials and patient care, we have seen the Time Machine Laser decrease and eliminate pain in the great majority of injuries whether at home, work, car or on the playing field. The efficacy and availability of our Laser is most timely with the worldwide opioid addiction crisis with far too many resultant deaths. We are committed to our mission to treat as many people as possible who are suffering with acute and chronic pain.”
Sonia Van Sickle has worked in business development for more than 25 years in the Latin American and US markets. For more than 15 years, she was in Marketing and Sales for Novartis Pharmaceutical in Latin America. She managed the distribution channels, legal, regulatory, logistics, marketing and sales of Novartis Ophthalmology, and OTC business units. She is a native of Guatemala, who currently lives in U.S., where she has continued to work in business development in the franchise world. She is also the current owner and Marketing Manager for Dimex S.A. in Guatemala, a company created for the import/export and distribution of products. Craig Van Sickle is the co-owner and General Manager of Dimex S. A. in Guatemala since 1995. He is introducing a new spa concept for South Florida and Puerto Rico for a successful Med Spa franchise which is one of the most successful business strategies in the market available today.
The company anticipates further related announcements and updates in the upcoming weeks and months.
About the Time Machine Laser
The Time Machine Laser is the only all-in-one, affordable, FDA cleared, Infrared, 2000mW power, small, hand-held portable laser marketed for pain relief in the U.S. The Time Machine Laser, which has been extensively tested and approved by Intertek for safety and electrical standards, has the power and frequency often found in large and expensive stationary units and at a fraction of the cost. Medifirst Solutions, Inc., in response to its Premarket Notification 510(k) submission for “The Time Machine” Series Laser, received clearance from the U.S. Food and Drug Administration (“FDA”) to market its infrared Time Machine TTML-8102000 Laser Thermal Therapeutic Device. The Laser is intended for use in temporary relief of minor muscle and joint pain, stiffness, minor arthritis pain, muscle spasm, temporary increase in local blood circulation and temporary relaxation of muscles by means of topical elevated tissue temperature from infrared spectral emissions. Visit www.medifirstsolutions.com for more information. Follow on Twitter @Medi_First and for Facebook visit Medifirst Solutions.
Forward-Looking Statements:
The statements in this press release that relate to the company’s expectations about the future impact on the company's results from new products in development are forward-looking statements, and may involve risks and uncertainties, some of which are beyond our control. Such risks and uncertainties are described in greater detail in our filings with the U.S. Securities and Exchange Commission. Since the information in this press release may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. We make no commitment to disclose any subsequent revisions to forward-looking statements. This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity.
Contact: Investor Relations
Phone: (732) 786-8044
Email: admin@medifirstsolutions.com
Website: www.medifirstsolutions.com
Source: Medifirst Solutions
(1)
(0)